Trial intelligence / Profile preview

Pantoprazole PK in Obese Children and Adolescents with GERD

NCT02186652Phase 1Completed

Start
Jun 2014
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of pantoprazole in gastroesophageal reflux disease (GERD). Started Jun 2014; status: completed.

02

Drugs

pantoprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on NCT02186652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02186652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call